Ditchcarbon
  • Contact
  1. Organizations
  2. Zentiva S.A.
Public Profile
Pharmaceutical Preparation Manufacturing
RO
updated a month ago

Zentiva S.A. Sustainability Profile

Company website

Zentiva S.A., a prominent player in the pharmaceutical industry, is headquartered in Romania (RO) and operates extensively across Central and Eastern Europe. Founded in 1998, the company has established itself as a leader in the production of generic medicines, focusing on high-quality, affordable healthcare solutions. Zentiva's core offerings include a diverse range of prescription and over-the-counter medications, with a commitment to innovation and sustainability that sets them apart in the market. The company has achieved significant milestones, including expanding its product portfolio and enhancing its manufacturing capabilities. With a strong market position, Zentiva is recognised for its dedication to improving patient access to essential medicines, making it a trusted name in the pharmaceutical sector.

DitchCarbon Score

How does Zentiva S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Zentiva S.A.'s score of 25 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.

37%

Let us know if this data was useful to you

Zentiva S.A.'s reported carbon emissions

Zentiva S.A., headquartered in Romania, currently does not have specific carbon emissions data available for the most recent year. The company has not disclosed any absolute emissions figures, including Scope 1, 2, or 3 emissions, nor has it set any documented reduction targets or climate pledges. As a current subsidiary, Zentiva S.A. may inherit climate-related data and commitments from its parent organisation, but specific details regarding these cascaded emissions or targets are not provided. The absence of reported emissions data and reduction initiatives suggests that Zentiva S.A. is still in the early stages of formalising its climate commitments within the pharmaceutical industry context. In summary, while Zentiva S.A. has not yet published specific emissions data or reduction targets, its relationship within a corporate family may influence its future climate strategies.

How Carbon Intensive is Zentiva S.A.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Zentiva S.A.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Zentiva S.A.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Zentiva S.A. is in RO, which has a low grid carbon intensity relative to other regions.

Zentiva S.A.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Zentiva S.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Zentiva S.A.'s Emissions with Industry Peers

Biofarm S.A.

RO
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Viatris

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Fresenius Kabi Aktiengesellschaft

DE
•
Real estate services (70)
Updated 3 months ago

Aurobindo Pharma

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251215.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy